Innovation for Life

Developing Innovative drugs, Biosimilars, Platforms, and Diagnostic technologies to improve lives.

Advancing Antibody Science

Advancing antibody drugs and biosimilars to address unmet medical needs.

Creating Value for a Healthier Life

Improving patient access through cost-effective, high-quality biosimilars.

PRESTIGE BIOPHARMA

PRESTIGE BIOPHARMA IDC

PRESTIGE BIOLOGICS

7

Beyond technological discovery, expanding access to care for patients around the world

Innovative Drug

Development of First-in-Class therapeutics for unmet diseases

Biosimilar

Prominent Biosimilars pipelines for accelerating market access

Platform Technology

A drug delivery platform that enhances treatment convenience

Diagnostics

Diagnostics for Pancreatic cancer by detecting PAUF

Prestige News

Total 66
Number Thumbnail Title Author Date Votes Views
16 Prestige Biopharma's Busan Innovative Drug Discovery Center (IDC) Designated as Advanced Investment Zone
김** | 2023.09.11 | Votes 0 | Views 346
김** 2023.09.11 0 346
15 Prestige Biopharma and Imagion Biosystems Sign an MOU, Developing Early Pancreatic Cancer Diagnosis Platform
김** | 2023.08.11 | Votes 0 | Views 368
김** 2023.08.11 0 368
14 Prestige Biopharma Submits EMA Marketing Authorization Application for Herceptin Biosimilar HD201
김** | 2023.07.31 | Votes 0 | Views 363
김** 2023.07.31 0 363
13 Prestige Biopharma Receives FDA Fast Track Designation for PBP1510 in the Treatment of Pancreatic Cancer
김** | 2023.03.16 | Votes 0 | Views 331
김** 2023.03.16 0 331
12 Prestige Biopharma Initiates Development of PAUF-Based Diagnostic Kit for Pancreatic Cancer
김** | 2023.03.09 | Votes 0 | Views 329
김** 2023.03.09 0 329
11 Prestige Biopharma Receives Approval for Phase 1 Trial of Humira Biosimilar in Hungary
김** | 2023.02.15 | Votes 0 | Views 315
김** 2023.02.15 0 315
10 Prestige Biopharma Secures Korean Patent for PBP1710, an Antibody Therapeutic for Solid Tumors
김** | 2023.01.10 | Votes 0 | Views 258
김** 2023.01.10 0 258
9 Prestige Biopharma Attracts Over 300 Companies to Its Booth at CPHI
we******** | 2022.11.07 | Votes 0 | Views 391
we******** 2022.11.07 0 391
8 Prestige Biopharma Identifies New Biomarker for Pancreatic Cancer Treatment
we******** | 2022.10.05 | Votes 0 | Views 349
we******** 2022.10.05 0 349
7 Prestige Biopharma Receives FDA Approval for Phase 1/2a Trial of Pancreatic Cancer Drug PBP1510
김** | 2022.06.27 | Votes 0 | Views 536
김** 2022.06.27 0 536

Read Prestige news >>